Researchers at the University of California have developed a new blood test called MethylScan, which shows promising potential for early detection of various types of cancer and liver diseases through a simple blood sample analysis.
Researchers at the University of California have developed a low-cost blood test that shows promising capabilities in early detection of various cancers and liver diseases. This breakthrough could revolutionize diagnostic methods.
Recent studies indicate a significant rise in liver transplant patients, increasingly linked to obesity and diabetes rather than viral hepatitis. This trend calls for preventive measures before liver-related diseases worsen.
A recent study reveals that regular exercise for eight weeks can significantly enhance liver health in patients with non-alcoholic fatty liver disease. This finding opens new avenues for treating this condition.